Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin
- PMID: 21148526
- DOI: 10.1093/cid/ciq072
Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin
Abstract
Mycobacterium ulcerans infection is responsible for severe skin lesions in sub-Saharan Africa. We enrolled 30 Beninese patients with Buruli ulcers in a pilot study to evaluate efficacy of an oral chemotherapy using rifampicin plus clarithromycin during an 8-week period. The treatment was well tolerated, and all patients were healed by 12 months after initiation of therapy without relapse.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
